Mycoplasma bovis causes serious diseases in cattle and is one of the most economically important pathogens threatening the global cattle industry. It is still a great challenge to prevent and control M. bovis infections owing to the increase in antibiotics resistance and unsatisfactorily effective commercial vaccines. FtsZ is commonly considered as a division protein in most bacteria. Owing to the limited genetic manipulation tools of M. bovis, the role of FtsZ in the pathogenicity of M. bovis remains unknown. In this study, FtsZ protein was found to be mainly distributed on the cell membrane, was highly conserved, and had good immunogenicity. FtsZ could bind to embryonic bovine lung cells (EBL) membrane extract, and this binding was inhibited by anti-FtsZ serum. In addition, FtsZ interacted with host extracellular matrix components fibronectin, laminin, vitronectin, and collagen IV in a dose-dependent manner, and promoted tissue diffusion by activating plasminogen through tissue plasminogen activator (tPA). Disruption of the ftsZ gene markedly reduced the adhesion of M. bovis to EBL cells while the complemented strain M. bovis ÎftsZ: ftsZ partly restored the adhesion ability. This is a first description that FtsZ acts as a novel adhesion protein in Mycoplasma, which interacts with host extracellular matrix components and plasminogen, and plays a vital role in adhesion and dissemination. This study expands our understanding of FtsZ significant role in the pathogenicity of M. bovis and provides a new potential vaccine and drug target against M. bovis infections.
FtsZ contributes to cytoadhesion and interaction with host extracellular matrix components and plasminogen in Mycoplasma bovis.
FtsZ 促进牛支原体细胞粘附,并与宿主细胞外基质成分和纤溶酶原相互作用。
阅读:2
| 期刊: | Veterinary Research | 影响因子: | 3.500 |
| 时间: | 2025 | 起止号: | 2025 Dec 12; 56(1):228 |
| doi: | 10.1186/s13567-025-01673-y | 研究方向: | 细胞生物学 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。